Botulinum neurotoxin composition
AssigneeMedytox Inc.
InventorsSeongsung KWAK, JinHee KWON, JaeYoon BYUN
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to a botulinum toxin composition which has an effect of reduced diffusion and/or an effect of extended duration.
Claims13
A method for treating a disease or improving a condition in a patient in need thereof, wherein the method comprises topically administering a therapeutically effective amount of botulinum toxin composition to a subject in need of treatment or improvement,
- wherein the botulinum toxin composition comprising a botulinum toxin as an active ingredient and free of animal protein,
- and
- at an administration site, diffusion is reduced compared to a botulinum toxin composition comprising animal protein.
A method for treating a disease or improving a condition in a patient in need thereof, wherein the method comprises topically administering a therapeutically effective amount of the botulinum toxin composition to a subject in need of treatment or improvement, wherein the composition comprising a non-complex botulinum toxin as an active ingredient and free of animal protein,
- and
- the composition has an effect at an administration site for a longer period of time than a botulinum toxin composition comprising animal protein.
-15. (canceled)
Dependencies are inferred from the claim text.